Yantai Zhenghai Biotechnology Co., Ltd.

300653

CNE100002NZ1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
22.8 ^CNY	0.00%		+0.13%	-21.43%

Apr. 03	Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	CI
Apr. 02	Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Dividend for the Year 2023	CI

Yantai Zhenghai Biotechnology Co., Ltd. Approves Profit Distribution Proposal for 2020

April 30, 2021 at 03:41 pm EDT

Yantai Zhenghai Biotechnology Co., Ltd. approved profit distribution proposal of CNY 2.50000000 per 10 shares (tax included) for 2020.

Latest news about Yantai Zhenghai Biotechnology Co., Ltd.

Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	Apr. 03	CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Dividend for the Year 2023	Apr. 01	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Zhenghai Bio-Tech Gets Nod for Oral Restorative Film	Mar. 14	MT
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	Jan. 03	CI
Yantai Zhenghai Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	Dec. 20	CI
Yantai Zhenghai Biotechnology Co., Ltd. authorizes a Buyback Plan.	Dec. 19	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-31	CI
Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023	23-05-23	CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-11	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Cash Dividend for the 2022	23-04-11	CI
Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial	23-02-22	MT
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-31	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022	22-05-12	CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend	22-04-27	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
Zhenghai Bio-Tech Bumps 2021 Dividend by 252% on Double-Digit Earnings Growth	22-03-01	MT
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021	22-03-01	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-19	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-05	CI

Chart Yantai Zhenghai Biotechnology Co., Ltd.

Duration

Period

Chart Yantai Zhenghai Biotechnology Co., Ltd.

More charts

Yantai Zhenghai Bio-Tech Co Ltd is a company engaged in production and sales of implantable medical devices. The Company has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Yantai Zhenghai Biotechnology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.8 CNY

Average target price

31.34 CNY

Spread / Average Target

+37.43%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.	-21.43%	566M
STRYKER CORPORATION	+12.49%	128B
SMITH & NEPHEW PLC	-8.87%	10.66B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-2.20%	8.55B
INSPIRE MEDICAL SYSTEMS, INC.	+15.12%	7.1B
GLAUKOS CORPORATION	+26.97%	5.06B
AXONICS, INC.	+7.09%	3.4B
ENOVIS CORPORATION	+0.27%	3.08B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.28%	2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-8.61%	2.03B

Medical Devices & Implants